ATARA Biotherapeutics (ATRA) Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive MS in Late-Breaking e-Poster at EAN

Go back to ATARA Biotherapeutics (ATRA) Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive MS in Late-Breaking e-Poster at EAN
(NASDAQ: ATRA) Delayed: 9.65 -0.61 (5.95%)
Previous Close $10.26    52 Week High $40.80 
Open $10.04    52 Week Low $12.45 
Day High $10.38    P/E N/A 
Day Low $9.50    EPS $0.00 
Volume 206,761